Metal Chemistry

Comprehensive carbohydrate chemistry capabilities supported by experienced teams and a strong focus on quality and scalability.

Specialized depot injection capabilities supporting long-acting therapeutic solutions.

Dedicated capabilities for genotoxic impurity characterization, supporting pharmaceutical partners in their quality and development requirements.

A range of granule-based formulations designed to support convenient and versatile drug delivery.

Specialized expertise in heterocyclic chemistry, supporting a broad range of pharmaceutical molecules and development needs.

Growing capabilities in hormone products, supported by strong pharmaceutical expertise, quality-focused processes and reliable supply for global partners.

A growing ophthalmic portfolio offering quality-focused solutions across diverse therapeutic requirements.

A diverse range of oral solutions designed for flexible and patient-friendly administration.

Quality-focused oral suspension formulations supporting diverse therapeutic applications and patient needs.

Pellet-based dosage forms offering flexible solutions for diverse pharmaceutical applications.

Convenient and patient-focused delivery formats designed for modern pharmaceutical needs.

Polymer chemistry capabilities supporting diverse pharmaceutical applications through strong expertise, quality and scalable solutions.

MSN Group is one of the fastest-growing, research-based and fully integrated pharmaceutical companies based out of Hyderabad, India. It was founded in the year 2003 with a mission to make high-quality medicines affordable and accessible to the world. The organization presently has 24 state-of-the-art manufacturing facilities (16 API and 8 Finished Dosage Facilities) established across India and USA. The group has an integrated R&D centre that facilitates the research of both API and Finished Dosages under one roof, enabling the organization to introduce new and affordable therapies in global markets swiftly.